Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $204B
1-Year Return 26.64%
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Quarter Return
+9.77%
1 Year Return
+26.64%
3 Year Return
+125.28%
5 Year Return
+196.8%
10 Year Return
+578.78%
AUM
$240B
AUM Growth
+$11.1B
Cap. Flow
-$6.03B
Cap. Flow %
-2.51%
Top 10 Hldgs %
24.58%
Holding
2,654
New
464
Increased
1,324
Reduced
690
Closed
110

Sector Composition

1 Technology 32.52%
2 Healthcare 18.41%
3 Consumer Discretionary 11.42%
4 Financials 9.67%
5 Industrials 8.57%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
HUMA icon
2501
Humacyte
HUMA
$233M
$98K ﹤0.01%
+13,513
New +$98K
CTLP icon
2502
Cantaloupe
CTLP
$794M
$96K ﹤0.01%
+10,850
New +$96K
WKHS icon
2503
Workhorse Group
WKHS
$19.2M
$96K ﹤0.01%
89
+45
+102% +$48.5K
MMAT
2504
DELISTED
Meta Materials Inc. Common Stock
MMAT
$96K ﹤0.01%
+390
New +$96K
AMRX icon
2505
Amneal Pharmaceuticals
AMRX
$2.99B
$94K ﹤0.01%
+19,621
New +$94K
MAPS icon
2506
WM Technology
MAPS
$125M
$92K ﹤0.01%
+15,471
New +$92K
HLX icon
2507
Helix Energy Solutions
HLX
$952M
$91K ﹤0.01%
29,068
+14,616
+101% +$45.8K
OCUL icon
2508
Ocular Therapeutix
OCUL
$2.24B
$91K ﹤0.01%
+13,073
New +$91K
RIGL icon
2509
Rigel Pharmaceuticals
RIGL
$715M
$91K ﹤0.01%
3,433
+1,727
+101% +$45.8K
IDEX
2510
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$91K ﹤0.01%
616
+311
+102% +$45.9K
RKLY
2511
DELISTED
Rockley Photonics Holdings Limited
RKLY
$91K ﹤0.01%
+20,985
New +$91K
MDXG icon
2512
MiMedx Group
MDXG
$1.06B
$89K ﹤0.01%
+14,712
New +$89K
VLDR
2513
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$89K ﹤0.01%
+19,148
New +$89K
INSG icon
2514
Inseego
INSG
$197M
$88K ﹤0.01%
+1,516
New +$88K
EGIO
2515
DELISTED
Edgio, Inc. Common Stock
EGIO
$86K ﹤0.01%
629
+316
+101% +$43.2K
KPTI icon
2516
Karyopharm Therapeutics
KPTI
$58.2M
$78K ﹤0.01%
+811
New +$78K
WTTR icon
2517
Select Water Solutions
WTTR
$910M
$78K ﹤0.01%
+12,522
New +$78K
VBIV
2518
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$78K ﹤0.01%
1,111
+553
+99% +$38.8K
VERU icon
2519
Veru
VERU
$48.3M
$75K ﹤0.01%
+1,274
New +$75K
MRSN icon
2520
Mersana Therapeutics
MRSN
$35.3M
$70K ﹤0.01%
+448
New +$70K
PGEN icon
2521
Precigen
PGEN
$1.36B
$69K ﹤0.01%
+18,572
New +$69K
AMWL icon
2522
American Well
AMWL
$109M
$68K ﹤0.01%
+559
New +$68K
MUX icon
2523
McEwen Inc.
MUX
$735M
$68K ﹤0.01%
7,681
+3,823
+99% +$33.8K
AKBA icon
2524
Akebia Therapeutics
AKBA
$801M
$67K ﹤0.01%
29,775
+15,030
+102% +$33.8K
ALTO icon
2525
Alto Ingredients
ALTO
$89M
$67K ﹤0.01%
+13,957
New +$67K